These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 30021196

  • 1. LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.
    Ling ZA, Xiong DD, Meng RM, Cen JM, Zhao N, Chen G, Li RL, Dang YW.
    Cell Physiol Biochem; 2018; 48(2):540-555. PubMed ID: 30021196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
    Kessler SM, Hosseini K, Hussein UK, Kim KM, List M, Schultheiß CS, Schulz MH, Laggai S, Jang KY, Kiemer AK.
    Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
    [Abstract] [Full Text] [Related]

  • 5. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y, Wen DY, Zhang R, Huang JC, Lin P, Ren FH, Wang X, He Y, Yang H, Chen G, Luo DZ.
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
    Mo M, Liu S, Ma X, Tan C, Wei L, Sheng Y, Song Y, Zeng X, Huang D, Qiu X.
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
    [Abstract] [Full Text] [Related]

  • 8. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN, Zhou J, Lu XJ.
    J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
    [Abstract] [Full Text] [Related]

  • 9. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
    Luo Y, Lin J, Zhang Y, Dai G, Li A, Liu X.
    Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
    [Abstract] [Full Text] [Related]

  • 10. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P, Wen DY, Li Q, He Y, Yang H, Chen G.
    Cell Physiol Biochem; 2018 Oct; 48(5):1953-1967. PubMed ID: 30092571
    [Abstract] [Full Text] [Related]

  • 11. NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.
    Tu J, Zhao Z, Xu M, Lu X, Chang L, Ji J.
    J Cell Physiol; 2018 Nov; 233(11):8578-8587. PubMed ID: 29797561
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
    Liu J, Wang Z, Yin Y, Li N, Ye NY, Bao B, Gu HC.
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
    [Abstract] [Full Text] [Related]

  • 13. HIF-2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial-mesenchymal transition.
    Zheng X, Zhang Y, Liu Y, Fang L, Li L, Sun J, Pan Z, Xin W, Huang P.
    J Cell Biochem; 2018 Apr; 119(4):3247-3256. PubMed ID: 29091312
    [Abstract] [Full Text] [Related]

  • 14. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY, Lin P, Pang YY, Chen G, He Y, Dang YW, Yang H.
    Med Sci Monit; 2018 May 05; 24():2786-2808. PubMed ID: 29728556
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD.
    World J Gastroenterol; 2019 Dec 28; 25(48):6902-6915. PubMed ID: 31908394
    [Abstract] [Full Text] [Related]

  • 16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR, Fang D, Di MP, Guan JL, Wang G, Liu L, Sheng JQ, Tian DA, Li PY.
    Int J Med Sci; 2020 Feb 19; 17(9):1224-1234. PubMed ID: 32547318
    [Abstract] [Full Text] [Related]

  • 18. lncRNA NEAT1 regulates the proliferation and migration of hepatocellular carcinoma cells by acting as a miR‑320a molecular sponge and targeting L antigen family member 3.
    Zhang Y, Huang C, Zhu Z, Hou Y, Huang S, Sun C, Tang Y, Zhang Z, Wang L, Chen H, Ju W, Qiao X, Chen M.
    Int J Oncol; 2020 Oct 19; 57(4):1001-1012. PubMed ID: 32945386
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 19; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
    Liu Z, Chang Q, Yang F, Liu B, Yao HW, Bai ZG, Pu CS, Ma XM, Yang Y, Wang TT, Guo W, Zhou XN, Zhang ZT.
    Eur J Surg Oncol; 2017 Sep 19; 43(9):1697-1703. PubMed ID: 28732670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.